A simple and sensitive fully validated HPLC-UV method for the determination of 5-fluorouracil and its metabolite 5.6-dihydrofluorouracil in plasma

被引:36
作者
Maring, JG
Schouten, L
Greijdanus, B
de Vries, EGE
Uges, DRA
机构
[1] Diaconessen Hosp Meppel, Dept Pharm, NL-7940 AM Meppel, Netherlands
[2] Bethesda Hosp Hoogeveen, NL-7940 AM Meppel, Netherlands
[3] Univ Groningen Hosp, Dept Pharm, Lab Drug Anal & Toxicol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen Hosp, Dept Med Oncol, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen, Ctr Pharm, NL-9713 AW Groningen, Netherlands
关键词
5-fluorouracil; 5,6-dihydrofluorouracil; HPLC; plasma;
D O I
10.1097/00007691-200502000-00006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
The authors developed a simple and sensitive, fully validated HPLC-UV method for the determination of both 5-FU and its metabolite DHFU in small-volume plasma samples. The analytes were separated on a 4.6 X 250 mm ID Atlantis dC18 5-mum column with isocratic elution at room temperature. Chlorouracil was used as internal standard. The analytes were detected with an UV diode array detector. DHFU was detected at 205 run, 5-FU at 266 nm, and chlorouracil at both wavelengths. The limits of quantification in plasma were 0.040 mug /mL for 5-FU and 0.075 mug/mL for DHFU. Linearity, accuracy, precision, recovery, dilution, freeze-thaw stability, and stability in the sample compartment were evaluated. The method appeared linear over a range from 0.04 to 15.90 mug/mL for 5-FU and from 0.075 to 3.84 mug/mL for DHFU. The method appeared very suitable for therapeutic drug monitoring and pharmacokinetic studies of 5-FU because of its simple extraction and small sample volume. Problems in earlier published methods with interfering peaks and variable retention times were overcome. The method appeared also to be suitable for detection of uracil and its metabolite dihydrouracil in plasma.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 26 条
[1]
Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography [J].
Ackland, SP ;
Garg, MB ;
Dunstan, RH .
ANALYTICAL BIOCHEMISTRY, 1997, 246 (01) :79-85
[2]
Bocci G, 2000, CLIN CANCER RES, V6, P3032
[3]
Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients [J].
Casale, F ;
Canaparo, R ;
Muntoni, E ;
Serpe, L ;
Zara, GP ;
Pepa, CD ;
Berno, E ;
Costa, M ;
Eandi, M .
BIOMEDICAL CHROMATOGRAPHY, 2002, 16 (07) :446-452
[4]
Known variant DPYD alleles do not explain DPD deficiency in cancer patients [J].
Collie-Duguid, ESR ;
Etienne, MC ;
Milano, G ;
McLeod, HL .
PHARMACOGENETICS, 2000, 10 (03) :217-223
[5]
A GAS-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF 5,6-DIHYDROFLUOROURACIL AND 5-FLUOROURACIL IN HUMAN-PLASMA [J].
DEBRUIJN, EA ;
DRIESSEN, O ;
VANDENBOSCH, N ;
VANSTRIJEN, E ;
SLEE, PHTJ ;
VANOOSTEROM, AT ;
TJADEN, UR .
JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02) :283-289
[6]
DETERMINATION OF THE CONCENTRATIONS OF 5-FLUOROURACIL AND ITS METABOLITES IN RABBIT PLASMA AND TISSUES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DELNOZAL, MJ ;
BERNAL, JL ;
PAMPLIEGA, A ;
MARINERO, P ;
POZUELO, M .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 656 (02) :397-405
[7]
High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes:: application to measurement of dihydropyrimidine dehydrogenase activity [J].
Déporte-Féty, R ;
Picot, M ;
Amiand, M ;
Moreau, A ;
Campion, L ;
Lanoë, D ;
Renée, N ;
Milano, G .
JOURNAL OF CHROMATOGRAPHY B, 2001, 762 (02) :203-209
[8]
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients [J].
Di Paolo, A ;
Ibrahim, T ;
Danesi, R ;
Maltoni, M ;
Vannozzi, F ;
Flamini, E ;
Zoli, W ;
Amadori, D ;
Del Tacca, M .
THERAPEUTIC DRUG MONITORING, 2002, 24 (05) :588-593
[9]
Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients [J].
Di Paolo, A ;
Danesi, R ;
Falcone, A ;
Cionini, L ;
Vannozzi, F ;
Masi, G ;
Allegrini, G ;
Mini, E ;
Bocci, G ;
Conte, PF ;
Del Tacca, M .
ANNALS OF ONCOLOGY, 2001, 12 (09) :1301-1306
[10]
FLEMING RA, 1992, CANCER RES, V52, P2899